Prosonix Ltd.

The Magdalen Centre Robert Robinson Avenue Oxford Science Park,
Oxford, OX4 4GA
United Kingdom,
44 18 6578 4250

Prosonix is a UK specialty pharmaceutical company focused on the development of a range of product candidates for the treatment of asthma and COPD. Prosonix's portfolio is based on its proprietary particle engineering technology and Prosonitron reactor system, which enables precise control of pharmaceutical product crystallisation during manufacture, and subsequent delivery characteristics.

Prosonix was acquired by Circassia Pharmaceutica on May 18, 2015.

Join Mergr to view all 251 acquisitions of medical products companies in 2015, including 19 acquisitions by private equity firms, and 232 by strategics.

Out of 60 sectors in the Mergr database, medical products ranked 10 in number of deals in 2015. The largest medical products acquisition in 2015 was Sirona Dental Systems - which was acquired by DENTSPLY International for $5.6B.

Join Mergr to view this profile - and discover more medical products acquisitions of companies like Prosonix.

What's Mergr?

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
  • 3.4K Private Equity Firms
  • 118K M&A Transactions
  • 128K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 2.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 35K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.